<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>404</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15707681</PubmedId>
            <Abstract>Epidermal growth factor is a potent growth-promoting factor for a variety of tissue cells in vivo and in vitro. Epidermal growth factor binds, phosphorylates, and activates epidermal growth factor receptors on the cell surface. In this study, we attempted to design functional peptide mimics by panning a phage display library on the anti-epidermal growth factor monoclonal antibody. By using anti-epidermal growth factor monoclonal antibody as a mold of the structure of the binding site of epidermal growth factor, high-efficiency probing was expected. From a random peptide phage display library, phage clones that bind to the anti-epidermal growth factor monoclonal antibody were isolated. One of the phage clones also exhibited binding activity to the epidermal growth factor receptor. The amino acid sequence of this phage clone showed slight similarity to the primary sequence of epidermal growth factor. We synthesized this motif to a 9-amino-acid intramolecularly disulfide-linked peptide. This synthetic peptide inhibited mitogenesis as well as epidermal growth factor receptor tyrosine phosphorylation, which is induced by epidermal growth factor. The present results suggest that the peptide synthesized in this study may mimic the epidermal growth factor receptor-binding region in epidermal growth factor.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>211-9</ArticlePages>
            <ArticleTitle>Peptide mimics of epidermal growth factor (EGF) with antagonistic activity.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Nakamura</LastName>
                    <ForeName>Takashi</ForeName>
                </Author>
                <Author>
                    <LastName>Takasugi</LastName>
                    <ForeName>Hiroshi</ForeName>
                </Author>
                <Author>
                    <LastName>Aizawa</LastName>
                    <ForeName>Tomoyasu</ForeName>
                </Author>
                <Author>
                    <LastName>Yoshida</LastName>
                    <ForeName>Masanobu</ForeName>
                </Author>
                <Author>
                    <LastName>Mizuguchi</LastName>
                    <ForeName>Mineyuki</ForeName>
                </Author>
                <Author>
                    <LastName>Mori</LastName>
                    <ForeName>Yoshihiro</ForeName>
                </Author>
                <Author>
                    <LastName>Shinoda</LastName>
                    <ForeName>Hiroyuki</ForeName>
                </Author>
                <Author>
                    <LastName>Hayakawa</LastName>
                    <ForeName>Yoichi</ForeName>
                </Author>
                <Author>
                    <LastName>Kawano</LastName>
                    <ForeName>Keiichi</ForeName>
                </Author>
            </Authors>
            <Affiliations>Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Toyama 930-0194, Japan.</Affiliations>
            <ArticleChemicalList>Peptide Library;Peptides;Epidermal Growth Factor</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; BALB 3T3 Cells; Carcinoma, Squamous Cell(immunology); Cell Line, Tumor; Epidermal Growth Factor(antagonists &amp; inhibitors; immunology); Humans; Mice; Molecular Mimicry(immunology); Peptide Library; Peptides(immunology); Protein Binding</ArticleMeshHeadingsList>
            <Journal>
                <Volume>116</Volume>
                <Issue>3</Issue>
                <Title>Journal of biotechnology</Title>
                <Issn>0168-1656</Issn>
                <MedlineTa>J Biotechnol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Clone 1</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>EHGAMEI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>DGVCMYI</LinearSequence>
                            <StartingPosition>17</StartingPosition>
                            <EndingPosition>23</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>AAS83395.1</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>12333</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Authors state this phage display sequence bears slight homology to human EGF. Authors utilized random peptide phage display library, panning for clones that bind to anti-epidermal growth factor mAb in search of peptide mimics.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1and figure 1</LocationOfData>
                        <BCellId>970</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAS83395.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>recombinant human EGF</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Data on immunization comes from Sigma-Aldrich product information for mAb EGF-10 product number E2520.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Binding specificity of phage-displayed epitope was compared to the binding to EGF Receptor (EGFR) and Mouse IgG (control).   Binding was detected with HRP-conjugated mouse anti-M13 mAb (Amersham-Pharmacia).  Binding did occur on the EGFR but to a signficantly reduced extent compared to binding to the EFG mAb.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Anti-EGF (EGF-10)</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Clone 1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <SequenceMoleculeNoNaturalSource>
                                        <ChemicalType>Peptide, no natural source</ChemicalType>
                                        <LinearSequence>EHGAMEI</LinearSequence>
                                    </SequenceMoleculeNoNaturalSource>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ObjectLibrary>
                                    <DisplaySystemType>Phage display</DisplaySystemType>
                                </ObjectLibrary>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

